Ticker Scorecard - NKTR Basics Company: Nektar Therapeutics IPO Date: May 3, 1994 Sector: Healthcare Industry: Pharma Market Cap: $171.95M Activated in VL: True Average Daily Range Avg Daily Range: $0.36 | 2.54% Avg Daily Range (30 D): $0.04 | 4.05% Avg Daily Range (90 D): $0.04 | 3.75% Institutional Daily Volume Avg Daily Volume: 1.45M Avg Daily Volume (30 D): 2.11M Avg Daily Volume (90 D): 1.81M Trade Size Avg Trade Size (Sh.): 167 Avg Trade Size (Sh.) (30 D): 334 Avg Trade Size (Sh.) (90 D): 292 Institutional Trades Total Inst.Trades: 8,952 Avg Inst. Trade: $2.66M Avg Inst. Trade (30 D): $.62M Avg Inst. Trade (90 D): $1.58M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.94M Avg Closing Trade (30 D): $.73M Avg Closing Trade (90 D): $.73M Avg Closing Volume: 220.53K     News Aug 9, 2024 @ 2:58 PM Nektar's (NKTR) Q2 Earnings Lag Estimates, Revenue... Source: N/A May 10, 2024 @ 3:33 PM Nektar's (NKTR) Q1 Earnings and Revenues Surpass E... Source: Zacks Equity Research Apr 10, 2024 @ 4:29 AM Nektar Therapeutics Sees Something In The Data And... Source: Biotech Beast Apr 3, 2024 @ 3:30 PM Nektar (NKTR) Up 7.5% Since Last Earnings Report: ... Source: Zacks Equity Research Mar 6, 2024 @ 5:33 PM Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alo... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.84 $-.18 $-.25 Diluted EPS $-.84 $-.18 $-.25 Revenue $ 93.14M $ 24.12M $ 23.49M Gross Profit $ 63.15M $ 19.69M $ 13.75M Net Income / Loss $ -168.3M $ -37.06M $ -52.36M Operating Income / Loss $ -153.06M $ -34.35M $ -49.77M Cost of Revenue $ 29.99M $ 4.44M $ 9.74M Net Cash Flow $ -34.81M $ 2.17M $ -20.7M PE Ratio     Splits Aug 23, 2000:   1:2